International Alfapump Cohort Study
← catalyst calendarNCT04326946 · readout in 865 d
Sponsored by Sequana Medical N.V. (industry) · SEQUA.BR — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
400estimated
Sites
2
Countries
Germany, Switzerland
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2018-08-14 | actual | When the study began enrolling |
| Primary completion | 2028-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2030-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2020-03-30 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-11-12 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Liver Cirrhoses
- Malignant Ascites
Intervention
- Device: Alfapump
Primary outcome
what the primary-completion date above is the date OFPatient survival at 6 months post implant
measured 6 months post-implant
Permalink · SEQUA.BR's whole pipeline · Catalyst calendar · Every registered study · What changed